• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过敏性肺炎的发病机制。

Pathogenesis of hypersensitivity pneumonitis.

作者信息

Girard Melissa, Israël-Assayag Evelyne, Cormier Yvon

机构信息

Institute of Cardiology and Pneumology Research Centre, Laval University, Laval Hospital, Quebec, Canada.

出版信息

Curr Opin Allergy Clin Immunol. 2004 Apr;4(2):93-8. doi: 10.1097/00130832-200404000-00004.

DOI:10.1097/00130832-200404000-00004
PMID:15021060
Abstract

PURPOSE OF REVIEW

Hypersensitivity pneumonitis is a group of immunologically mediated diseases caused by an abnormal response to a wide variety of inhaled antigens. Its pathogenesis is complex and involves many immunological concepts. This review discusses recent advances in our understanding of the pathogenesis of hypersensitivity pneumonitis.

RECENT FINDINGS

Over the last 3 years, several studies on the pathogenesis of hypersensitivity pneumonitis have been published. New antigens have been identified. We now have a better understanding of the role of inflammatory cells and mediators, and promoting and protective factors have been suggested.

SUMMARY

Most of the mechanisms involved in the pathogenesis of hypersensitivity pneumonitis remain incompletely understood. Current and future findings will not only help our understanding of the disease and its prevention, but also improve its treatment.

摘要

综述目的

过敏性肺炎是一组由对多种吸入性抗原的异常反应引起的免疫介导性疾病。其发病机制复杂,涉及许多免疫学概念。本综述讨论了我们对过敏性肺炎发病机制理解的最新进展。

最新发现

在过去3年里,发表了几项关于过敏性肺炎发病机制的研究。已鉴定出新的抗原。我们现在对炎症细胞和介质的作用有了更好的理解,并提出了促进因素和保护因素。

总结

过敏性肺炎发病机制中涉及的大多数机制仍未完全了解。当前和未来的研究结果不仅将有助于我们对该疾病及其预防的理解,还将改善其治疗。

相似文献

1
Pathogenesis of hypersensitivity pneumonitis.过敏性肺炎的发病机制。
Curr Opin Allergy Clin Immunol. 2004 Apr;4(2):93-8. doi: 10.1097/00130832-200404000-00004.
2
New aspects of hypersensitivity pneumonitis.
Curr Opin Pulm Med. 2004 Sep;10(5):378-82. doi: 10.1097/01.mcp.0000133067.71469.b2.
3
Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 3. Immunological lung disease--recent advances in the pathogenesis of hypersensitivity pneumonitis.呼吸系统疾病分子发病机制及其临床意义研讨会。3. 免疫性肺病——过敏性肺炎发病机制的最新进展。
Intern Med. 2001 Feb;40(2):164-7. doi: 10.2169/internalmedicine.40.164.
4
Hypersensitivity pneumonitis.过敏性肺炎
West J Med. 1993 Nov;159(5):570-8.
5
Hypersensitivity pneumonitis: correlation of cellular and immunologic changes with clinical phases of disease.过敏性肺炎:细胞及免疫变化与疾病临床阶段的相关性
Lung. 1988;166(4):189-208. doi: 10.1007/BF02714049.
6
Immunology of hypersensitivity pneumonitis.
Crit Rev Toxicol. 1982;11(1):15-32. doi: 10.3109/10408448209089847.
7
[Actualities in extrinsic allergic alveolities or hypersensitivity pneumonitis].
Dakar Med. 2007;52(1):31-6.
8
[Hypersensitivity pneumonitis].[过敏性肺炎]
Tuberk Toraks. 2011;59(2):194-204. doi: 10.5578/tt.2430.
9
Hypersensitivity pneumonitis.过敏性肺炎
Clin Chest Med. 1983 Jan;4(1):55-62.
10
Extrinsic allergic alveolitis with IgA deficiency.伴有IgA缺乏的外源性过敏性肺泡炎
Eur J Med Res. 2004 Dec 22;9(12):573-4.

引用本文的文献

1
ITGAV, a specific biomarker associated with the pathogenesis of idiopathic pulmonary fibrosis.整合素αV(ITGAV),一种与特发性肺纤维化发病机制相关的特异性生物标志物。
Sci Rep. 2025 May 15;15(1):16969. doi: 10.1038/s41598-025-01459-4.
2
Diagnosis and Treatment of Hypersensitivity Pneumonitis: S2k Guideline of the German Respiratory Society and the German Society for Allergology and Clinical Immunology.过敏性肺炎的诊断与治疗:德国呼吸学会和德国变态反应与临床免疫学会S2k指南
Respiration. 2025;104(7):485-528. doi: 10.1159/000543675. Epub 2025 Jan 27.
3
A Gene-Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis.
吸烟和基因多态性之间的基因-环境相互作用为两种结节病亚群提供了高风险。
Sci Rep. 2019 Dec 9;9(1):18633. doi: 10.1038/s41598-019-54612-1.
4
Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management.纤维化性过敏性肺炎:诊断与管理的关键问题
J Clin Med. 2017 Jun 15;6(6):62. doi: 10.3390/jcm6060062.
5
A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.一种鞘氨醇-1-磷酸受体 1 激动剂可抑制肺部三级淋巴组织的再激活和过敏反应。
Mucosal Immunol. 2018 Jan;11(1):112-119. doi: 10.1038/mi.2017.37. Epub 2017 Apr 19.
6
Significance of Foxp3+CD4+ regulatory T cells in the peripheral blood of Uygur patients in the acute and chronic phases of pigeon breeder's lung.鸽饲者肺急慢性期维吾尔族患者外周血中Foxp3 + CD4 + 调节性T细胞的意义
Bosn J Basic Med Sci. 2017 Feb 21;17(1):17-22. doi: 10.17305/bjbms.2016.1233.
7
A critical role of Dectin-1 in hypersensitivity pneumonitis.Dectin-1在过敏性肺炎中的关键作用。
Inflamm Res. 2016 Mar;65(3):235-44. doi: 10.1007/s00011-015-0910-1. Epub 2015 Dec 7.
8
Perinatal Immunization With Vaccine-Grade Listeria monocytogenes Provides Protection Against Murine Th2 Airway Inflammation.用疫苗级李斯特菌进行围产期免疫可预防小鼠 Th2 气道炎症。
Allergy Asthma Immunol Res. 2014 Jul;6(4):341-9. doi: 10.4168/aair.2014.6.4.341. Epub 2014 Mar 21.
9
TLR9-dependent IL-23/IL-17 is required for the generation of Stachybotrys chartarum-induced hypersensitivity pneumonitis.TLR9 依赖性的 IL-23/IL-17 对于构巢曲霉诱导的过敏性肺炎的发生是必需的。
J Immunol. 2013 Jan 1;190(1):349-56. doi: 10.4049/jimmunol.1202225. Epub 2012 Nov 23.
10
Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent.茎点青霉相关性过敏性肺炎依赖于 TLR9。
Am J Pathol. 2011 Dec;179(6):2779-87. doi: 10.1016/j.ajpath.2011.08.019. Epub 2011 Oct 5.